Ligand Pharmaceuticals Incorporated Stock Agreements

22 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Director Compensation and Stock Ownership Policy, as amended and restated effective August 4, 2023
Stock Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
2023
Director Compensation and Stock Ownership Policy, as amended and restated effective April 19, 2023
Stock Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
2023
Director Compensation and Stock Ownership Policy, as amended and restated, effective April 13, 2020
Stock Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
2023
Form of Restricted Stock Unit Award Agreement under the Companys 2022 Employment Inducement Plan
Stock Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
CA
2022
Form of Stock Option Agreement under the Companys 2022 Employment Inducement Plan
Stock Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
CA
2022
Contingent Value Rights Agreement, dated as of September 30, 2020, by and between Ligand Pharmaceuticals Incorporated and American Stock Transfer & Trust Company, LLC
Stock Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
DE
2020
Amended and Restated Director Compensation and Stock Ownership Policy, effective March 28, 2019
Stock Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
2020
LIGAND PHARMACEUTICALS INCORPORATED DIRECTOR COMPENSATION AND STOCK OWNERSHIP POLICY (Amended and Restated Effective March [ ], 2014) I. DIRECTOR COMPENSATION
Stock Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
2016
LIGAND PHARMACEUTICALS INCORPORATED NOTICE OF GRANT OF STOCK OPTION
Stock Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
CA
2014
LIGAND PHARMACEUTICALS INCORPORATED DOCS ATM financing facility $24,000,000 of Common Stock, $0.001 par value SALES AGREEMENT October 11, 2013
Stock Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
2013
LIGAND PHARMACEUTICALS INCORPORATED Common Stock (par value $0.001 per share) At the Market Issuance Sales Agreement
Stock Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2013
LIGAND PHARMACEUTICALS INCORPORATED Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales Agreement
Stock Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
NY
2012
LIGAND PHARMACEUTICALS INCORPORATED DIRECTOR COMPENSATION AND STOCK OWNERSHIP POLICY (Amended and Restated Effective April 16, 2009) I. DIRECTOR COMPENSATION
Stock Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
2009
PHARMACOPEIA, INC. 2000 STOCK OPTION PLAN
Stock Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
DE
2009
AMENDMENT TO RESTRICTED STOCK AGREEMENT
Stock Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
2008
AMENDMENT TO RESTRICTED STOCK AGREEMENT
Stock Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
2008
Common stock offered
Stock Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
2006
Common stock offered
Stock Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
CA
2006
Common stock offered
Stock Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
CA
2006
Common stock offered
Stock Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
CA
2006
Common stock offered
Stock Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
CA
2006
Common stock offered
Stock Agreements
Ligand Pharmaceuticals Incorporated
Biotechnology
2006